Expression of basic fibroblast growth factor is necessary but insufficient for production of metastasis

International Journal of Oncology

Volumn 10, Issue 1, 1997, Pages 23-31

  Singh, Rakesh K ^a   Reich, Reuven ^a   Radinsky, Robert ^a   Berry, Karen K ^a   Dave, Bhavana J ^a   Fidler, Isaiah J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Basic fibroblast growth factor; Collagenase IV Gelatinase; Metastatic phenotype; Murine K 1735 melanoma cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031024414     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.1.23     Document Type: Article

References (56)

1. Fidler IJ: Critical factors in the biology of human cancer metastasis. Cancer Res 50: 6130-6138, 1990.
2. Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res 47: 1473-1487, 1987.
3. Poste G and Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 139-146, 1980.
4. Clark WH: Tumor progression and the nature of cancer. Br J Cancer 64: 634-644, 1991.
5. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71, 1992.
6. Folkman J: Angiogenesis in cancer, vascular rheumatoid and other diseases. Nature Med 1: 27-31, 1995.
7. Baird A and Klagsbrun M: The fibroblast growth factor family. Cancer Cells 3: 239-251, 1991.
8. Rodeck U, Roder D and Herlyn M: Basic fibroblast growth factor in human melanoma. Cancer Cells 3: 308-311, 1991.
9. Herlyn M: Human melanoma: development and progression. Cancer Metastasis Rev 9: 101-129, 1990.
10. Halaban R, Ghosh S and Baird A: bFGF is the putative natural growth factor for human melanocytes. In Vitro Cell Dev Biol 23: 47-52, 1987.
11. Halaban R, Langdon R, Birchall N, Cuono C, Baird A, Scott G, Moellmann G and McGuire J: Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 107: 1611-1619, 1988.
12. Halaban R, Kwon BS, Ghosh S, Delli-Bovi P and Baird A: bFGF is an autocrine growth factor for human melanomas. Oncogene Res 3: 177-186, 1988.
13. Denijin M and Ruiter DJ: The possible role of angiogenesis in the metastatic potential of human melanoma. Melanoma Res 3: 5-14, 1993.
14. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS and White WL: Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanoma. Am J Pathol 145: 570-574, 1994.
15. Nanus DM, Schmitz-Drager BJ, Motzer RJ, Lee AC, Vlamis V, Cordon Cardo C, Albino AP and Reuter VE: Expression of basic fibroblast growth factor in primary renal tumor: correlation with poor survival. J Natl Cancer Inst 25: 1597-1599, 1994.
16. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19, 1995.
17. Singh RK, Bucana CD, Gutman M, Fan D, Wilson MR and Fidler IJ: Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am J Pathol 145: 365-374, 1994.
18. Kerbel RS: Expression of multi-cytokine resistance and multigrowth factor independence in advanced stage metastatic cancer (commentary). Am J Pathol 141: 519-524, 1992.
19. Liotta LA: Gene products which play a role in cancer invasion and metastasis. Breast Cancer Res 11: 113-124, 1988.
20. Presta M, Maier JA and Ragnotti G: The mitogenic signaling pathway but not the plasminogen activator-inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J Cell Biol 109: 1877-1884, 1989.
21. Buckley-Sturrock A, Woodward SC, Senior RM, Griffin GL, Klagsbrun M and Davidson JM: Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J Cell Physiol 138: 70-78, 1989.
22. Moscatelli D, Presta M and Rifkin DB: Purification of a factor from human placenta that stimulates capillary endothelial cell protease production. DNA synthesis, and migration. Proc Natl Acad Sci USA 83: 2091-2095, 1986.
23. Basilico C and Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-165, 1992.
24. Schulze-Osthoff K, Risau W, Vollmer E and Sorg C: In situ detection of basic fibroblast growth factor by specific antibodies. Am J Pathol 137: 85-92, 1990.
25. Zagzag D, Miller DC, Sato Y, Rifkin DB and Burstein DE: Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 50: 7393-7398, 1990.
26. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T and Nagura H: Immunocytochemical localization of basic fibroblast growth factor in carcinoma and inflammatory lesions of human digestive tract. Lab Invest 68: 520-527, 1993.
27. Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H and Hatanaka M: Gene expression of basic fibroblast growth factor in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87: 5710-5714, 1990.
28. Statuto M, Ennas MG, Zamboni G, Bonetti F, Pea M, Pozzi A, Rusnati M, Gualandris A and Presta M: Basic fibroblast growth factor in human pheochromocytoma: a biochemical and immunohistochemical study. Int J Cancer 53: 5-10, 1993.
29. Yamanaka Y, Friess H, Buchler M, Begger HG, Uchida E, Onada M and Kobrin MS: Overexpression of acidic and basic fibroblast growth factor in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 53: 5289-5296, 1993.
30. Kripke ML: Speculation on the role of ultraviolet radiation in development of malignant melanoma. J Natl Cancer Inst 36: 541-548, 1978.
31. Fidler IJ, Gruys E, Cifone MA, Barnes Z and Bucana CD: Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Natl Cancer Inst 67: 947-956, 1981.
32. Talmadge JE and Fidler IJ: Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Cancer Inst 69: 975-980, 1982.
33. Dotto GP, Moellmann G, Ghosh S, Edwards M and Halaban R: Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J Cell Biol 109: 3115-3128, 1989.
34. Radinsky R, Kraemer PM, Raines MA, Kung HJ and Culp LA: Amplification and rearrangement of Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression. Proc Natl Acad Sci USA 84: 5143-5147, 1987.
35. Wellstein A, Zugmaier G, Califano JA, Kern F, Paik S and Lippman ME: Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J Natl Cancer Inst 83: 716-720, 1991.
36. Chen C and Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745-2752, 1987.
37. Fort P, Marty L, Piechaczyk M, Sabrouty SE, Dani C, Jeanteur P and Blanchard JM: Various rat adult tissues express only one major mRNA species from glyceraldehyde 3-phosphate dehydrogenase multigenic family. Nucleic Acid Res 13: 1431-1442, 1985.
38. Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerried KA, Gospodarwicz D and Fiddes JC: Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233: 545-548, 1986.
39. Southern PJ and Berg P: Transformation of mammalian cells to antibiotic resistant with a gene under control of the SV40 early gene promoter. J Mol Appl Genet 1: 327-341, 1982.
40. Feinberg AP and Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13, 1988.
41. Li L, Price JE, Fan D, Zhang RD, Bucana CD and Fidler IJ: Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J Natl Cancer Inst 81: 1406-1412, 1989.
42. Fidler IJ, Li L, Ananthaswamy HN, Esumi N, Radinsky R and Price JE: Correlation of growth capacity of cells in hard agarose with successful transfection by activated C-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites. Anticancer Res 11: 17-24, 1991.
43. Nakajima M, Morikawa K, Fabra A, Bucana CD and Fidler IJ: Influence of organ microenvironment on extracellular matrix degradation and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890-1898, 1990.
44. Pathak S, Staroselsky AN and Fidler IJ: Specific chromosomal defects associated with metastatic potential in K-1735 melanoma clone: involvement of chromosomes 4 and 14. Cancer Genet Cytogenet 56: 209-221, 1991.
45. Houghton AN, Eisinger M, Albino AP, Caimcross JG and Old LJ: Surface antigens of melanocytes and melanomas: markers of melanocyte differentiation and melanoma subsets. J Exp Med 156: 1755-1766, 1982.
46. Herlyn M, Iliopoulos D, Jensen PJ, Parmiter A, Baird J, Hotta H, Adachi K, Ross AH, Jambrosic J, Koprowski H and Herlyn M: In vitro properties of human melanoma cells metastatic in nude mice. Cancer Res 50: 2296-2302, 1990.
47. Fidler IJ and Radinsky R: Genetic control of cancer metastasis (Editorial). J Natl Cancer Inst 82: 166-168, 1990.
48. Aukerman SL, Price JE and Fidler IJ: Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735 melanoma cells from producing metastases. J Natl Cancer Inst 77: 915-924, 1986.
49. Hart IR, Goode NT and Wilson RE: Molecular aspects of the metastatic cascade. Biochim Biophys Acta 989: 65-84, 1989.
50. Staroselsky AH, Pathak S, Chernajovsky Y, Tucker SL and Fidler IJ: Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res 51: 6292-6298, 1991.
51. Rogelj S, Weinberg RA, Fanning P and Klagsbrun M: Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 331: 173-175, 1988.
52. Sasada R, Kurokawa T, Iwane M and Igarashi R: Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA. Mol Cell Biol 8: 588-594, 1988.
53. Blam SB, Mitchell R, Tischer E, Rubin JS, Silva M, Silver S, Fiddes JC, Abraham JA and Aaronson SA: Addition of growth hormone secretion signal to basic fibroblast growth factor results in cell transformation and secretion of aberrant forms of the protein. Oncogene 3: 129-136, 1988.
54. Fernig DG and Gallagher JT: Fibroblast growth factors: an information network controlling tissue growth, morphogenesis, and repair. Prog Growth Factor Res 5: 353-377, 1994.
55. Davies BR, Fernig DG, Barraclough R and Rudland PS: Effect on tumorigenicity and metastasis of transfection of a diploid benign rat mammary epithelial cell line with DNA corresponding to the mRNA for basic fibroblast growth factor. Int J Cancer 65: 104-111, 1996.
56. Coltrini D, Gualandris A, Nelli EE, Parolini S, Molinari-Tosatti MP, Quarto N, Ziehe M, Giavazzi R and Presta M: Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export dependent mechanism. Cancer Res 55: 4729-4738, 1995.